atit In virtually defines
all mortality in patients with viral hepatitis. The term hepatitis B approved in 1973
Scientific team of WHO experts. Previously, hepatitis B are designated as seasm hepatitis,
hepatitis that is transmitted parenterally, etc.
What he's dangerous?
Hepatitis B is characterized by high morbidity and mortality. No less important
is the fact that in the long term disease is accompanied by a threat
development of liver tumors and cirrhosis, especially in those patients who were
infected in childhood. Hepatitis B viass infected about two billion
people and kills about two million people. Sources of infection
are patients with acute and chronic hepatitis B carriers (about 300-350
million), many of whom are unaware of the viass infection.
Who should be vaccinated?
Russian Ministry of Health recommends that:
Phased introduction of hepatitis B immunization among children and the introduction of immunization
Hepatitis B among high-risk adults.
Russian Ministry of Health recommends vaccination of the following groups of children:
Stage 1
infants born to mothers - carriers of the viass or hepatitis
B;
all newborns in the regions with higher prevalence of carriage of HbsAg
5%;
children, whose families have the support of HbsAg or patients with chronic HBV;
children orphanages and boarding schools;
children regularly receiving blood and blood products, as well as in hemodialysis;
Stage 2 vaccine provides coverage for all children within the calendar
vaccinations
third stage vaccine provides coverage for all adolescents
Russian Ministry of Health recommends vaccination of the following groups of adults:
health workers who have contact with blood, especially surgeons,
gynecologists, obstetricians, dentists, nurses manipulation, office staff
blood transfusion and dialysis, laboratory workers, etc. high risk, vaccination that may be recommended:
hemophiliacs who receive blood donations, donors, patients receiving
transplants;
people using the services of a cosmetologist;
policemen, soldiers, firemen, rescue workers, mortuary workers
etc.;
people traveling to Russia and worldwide;
people who use dasgs intravenously;
family members or the immediate environment of carriers HbsAg;
other groups, the vaccination that may be helpful;
all citizens of Russia can be attributed to the high risk group, as
our country the prevalence of disease is very high (35 cases
per 100 000 population in European countries).